Product Information
DIAZEPAM 25 MG/5 ML ORAL CONC is a generic product labeled by Chartwell RX LLC, priced at $1.0620 per ML under NDC 62135076843. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Apr 14, 2014. Its Orange Book therapeutic-equivalence code is AA.
Strength
5 mg/mL
Manufacturer
Chartwell RX LLCNDC
62135076843
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DIAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA204433FDA Approved
4/14/2014
TE Code
AA
On Market Since
4/14/2014
Pharmacological Classes
Price Statistics
The NADAC for DIAZEPAM 25 MG/5 ML ORAL CONC has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 4.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0620 per ML |
|---|---|
| All-time high | $1.0620 (Sep 30, 2026) |
| All-time low | $0.9358 (Aug 21, 2024) |
| 52-week high | $1.0620 |
| 52-week low | $0.9845 |
| Median price | $1.0004 |
| Average price | $1.0003 |
| Largest weekly change | -8.8% (Jul 17, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Diazepam Oral Solution (Concentrate) market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diazepam Oral Solution (Concentrate) market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIAZEPAM 25 MG/5 ML ORAL CONC?
The current National Average Drug Acquisition Cost (NADAC) for DIAZEPAM 25 MG/5 ML ORAL CONC, manufactured by Chartwell RX LLC, is $1.0620 per ML (NDC 62135076843), effective Sep 30, 2026.
How has the price of DIAZEPAM 25 MG/5 ML ORAL CONC changed over time?
Over the history we have for it, the NADAC for DIAZEPAM 25 MG/5 ML ORAL CONC has risen 4.5%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for DIAZEPAM 25 MG/5 ML ORAL CONC?
Since Apr 17, 2024, the NADAC for DIAZEPAM 25 MG/5 ML ORAL CONC has ranged from a low of $0.9358 (Aug 21, 2024) to a high of $1.0620 (Sep 30, 2026), with a median of $1.0004 per ML.
Are there cheaper alternatives to DIAZEPAM 25 MG/5 ML ORAL CONC?
No other NADAC-published product currently shares the active ingredient and strength of DIAZEPAM 25 MG/5 ML ORAL CONC in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DIAZEPAM 25 MG/5 ML ORAL CONC?
DIAZEPAM 25 MG/5 ML ORAL CONC (NDC 62135076843) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.